2 Days_1777370193195_831968492.png&w=48&q=75)
Source:
The Columbus Dispatch
_1777370220974_847775619.png&w=48&q=75){kind=small}
Ohio study links GLP-1 drugs to restaurant issues
A recent study indicates that the increasing use of GLP-1 weight-loss drugs, such as Ozempic and Wegovy, is leading Americans to dine out less and modify their eating habits. Two-thirds of users reported reduced spending at restaurants, with many cutting back on desserts, sugary drinks, and alcoholic beverages. As a result, the restaurant industry may need to adapt by offering smaller portions and high-protein options to meet changing consumer preferences.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)